Multidisciplinary recommendations for routine follow-up of isocitrate dehydrogenase‑mutant glioma in 2026: Adapting clinical practice to the molecular era
- DOI
- 10.1093/nop/npag032
- Published
- 2026-04-10
- Container
- Neuro-Oncology Practice
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/nop/npag032,
title = {Multidisciplinary recommendations for routine follow-up of isocitrate dehydrogenase‑mutant glioma in 2026: Adapting clinical practice to the molecular era},
author = {Mary Jane Lim-Fat and Amelie Darlix and Bogdana Suchorska and Antonella Castellano and Giuseppe Minniti and Maarten Wijnenga and Susan C Short and Martin J van den Bent},
year = {2026},
journal = {Neuro-Oncology Practice},
doi = {10.1093/nop/npag032},
url = {https://doi.org/10.1093/nop/npag032}
}RIS
TY - JOUR TI - Multidisciplinary recommendations for routine follow-up of isocitrate dehydrogenase‑mutant glioma in 2026: Adapting clinical practice to the molecular era AU - Mary Jane Lim-Fat AU - Amelie Darlix AU - Bogdana Suchorska AU - Antonella Castellano AU - Giuseppe Minniti AU - Maarten Wijnenga AU - Susan C Short AU - Martin J van den Bent PY - 2026 JO - Neuro-Oncology Practice DO - 10.1093/nop/npag032 UR - https://doi.org/10.1093/nop/npag032 ER -
APA
Lim-Fat, M. J., Darlix, A., Suchorska, B., Castellano, A., Minniti, G., Wijnenga, M., Short, S. C., & Bent, M. J. V. D. (2026). Multidisciplinary recommendations for routine follow-up of isocitrate dehydrogenase‑mutant glioma in 2026: Adapting clinical practice to the molecular era. Neuro-Oncology Practice. https://doi.org/10.1093/nop/npag032
Source records
- crossref · retrieved 2026-09-25T18:11:04.264Z